Integer (NYSE:ITGR - Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 5.240-5.430 for the period, compared to the consensus estimate of 5.300. The company issued revenue guidance of $1.7 billion-$1.7 billion, compared to the consensus revenue estimate of $1.7 billion. Integer also updated its FY24 guidance to $5.24-5.43 EPS.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on ITGR shares. Citigroup lifted their price target on shares of Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a research note on Tuesday, October 1st. Oppenheimer initiated coverage on shares of Integer in a research note on Tuesday, July 16th. They set an "outperform" rating and a $135.00 target price for the company. KeyCorp raised their target price on Integer from $139.00 to $144.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 15th. Benchmark upped their price target on Integer from $130.00 to $140.00 and gave the company a "buy" rating in a report on Monday. Finally, Truist Financial raised their price objective on shares of Integer from $145.00 to $150.00 and gave the stock a "buy" rating in a report on Monday, October 14th. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $140.14.
Get Our Latest Stock Analysis on Integer
Integer Stock Performance
NYSE:ITGR traded up $0.31 during mid-day trading on Thursday, reaching $126.84. 524,924 shares of the stock were exchanged, compared to its average volume of 312,988. The stock has a market capitalization of $4.25 billion, a P/E ratio of 43.86, a P/E/G ratio of 1.86 and a beta of 1.08. Integer has a 1 year low of $69.40 and a 1 year high of $133.53. The company has a 50 day simple moving average of $127.37 and a 200-day simple moving average of $120.86. The company has a quick ratio of 1.96, a current ratio of 3.29 and a debt-to-equity ratio of 0.73.
Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating the consensus estimate of $1.36 by $0.07. The firm had revenue of $431.42 million during the quarter, compared to the consensus estimate of $440.59 million. Integer had a net margin of 6.31% and a return on equity of 11.48%. Integer's revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.27 EPS. Analysts anticipate that Integer will post 5.3 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Integer news, Director Jean M. Hobby sold 11,960 shares of Integer stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total value of $1,431,133.60. Following the sale, the director now owns 2,280 shares of the company's stock, valued at approximately $272,824.80. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 2.00% of the company's stock.
Integer Company Profile
(
Get Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
See Also
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.